American Bio Medica Corporation manufactures and markets accurate, cost-effective immunoassay test kits, primarily point of collection tests for drugs of abuse. The Company and its worldwide distribution network target the workplace, government, corrections, clinical and educational markets. ABMC’s Rapid Drug Screen®, Rapid ONE®, RDS® InCup®, Rapid TOX® and Rapid TOX Cup® II test for the presence or absence of drugs of abuse in urine, while OralStat® tests for the presence or absence of drugs of abuse in oral fluids. ABMC’s Rapid Reader® is a compact, portable device that, when connected to any computer, interprets the results of an ABMC drug screen, and sends the results to a data management system, enabling the test administrator to easily manage their drug testing program.

Company profile
Ticker
ABMC
Exchange
Website
CEO
Melissa A. Waterhouse
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
IRS number
141702188
ABMC stock data
Calendar
16 May 22
12 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 17K | 17K | 17K | 17K | 17K | 17K |
Cash burn (monthly) | 32.67K | 3.83K | 110.33K | 83.42K | 4.33K | 27.25K |
Cash used (since last report) | 144.24K | 16.93K | 487.19K | 368.33K | 19.13K | 120.32K |
Cash remaining | -127.24K | 73.57 | -470.19K | -351.33K | -2.13K | -103.32K |
Runway (months of cash) | -3.9 | 0.0 | -4.3 | -4.2 | -0.5 | -3.8 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Jul 21 | Moroney John J | Common Stock | Sell | Dispose S | Yes | No | 0.061 | 495,500 | 30.23K | 1,986,108 |
Institutional ownership, Q1 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0 |
Total shares | 0 |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ABMC, advisory, arise, asset, assistance, attract, blended, Breakup, bringing, China, Code, consulting, decision, desire, disclosed, DOA, easily, effort, evidenced, exclusively, federal, footnote, fully, hereinafter, high, immaterial, impose, imposed, introduced, invocation, invoked, involve, involving, labeled, Landmark, largest, leverage, liability, low, margin, mentioned, million, modification, multiple, NOL, outlined, overnight, past, payoff, percent, percentage, poor, prohibitive, projected, proving, provision, receipt, recognition, reconciliation, referred, refinanceor, reflect, rejected, reliability, repaid, repair, reverse, saturated, schedule, segment, shortly, spoke, statutory, strike, sustained, taxable, temporary, Tern, twelve, unaffiliated, uninterrupted, valuation, vest, WaterhouseChief, writing
Removed:
accelerated, accounted, accredited, added, addressed, agent, aggregate, amortization, announced, apply, arose, bankruptcy, blood, calculating, car, care, Cassette, certainty, Chaim, Chairman, charged, classify, CLIA, clinical, close, combination, commence, commencement, commitment, communicate, comparability, complexity, comply, conform, consistent, consummated, contracting, convertible, core, counsel, covenant, cured, customary, declare, departure, detect, disease, diversity, dollar, embedded, executed, experiencing, Finally, finance, flat, force, formula, forward, franchise, frequency, funding, global, granted, guaranteed, hand, Healgen, holding, improvement, inclusion, incur, indemnification, initiate, instructed, intend, investor, irrevocable, Jersey, Joint, level, Logix, longer, manufacturer, media, minimal, normalcy, notified, operation, order, placement, plasma, point, practice, preferred, prepaid, prepay, present, presumption, proportionate, rebated, rebut, reclassified, recur, removed, removing, request, requiring, rescinding, Respiratory, revise, sample, Scientific, separately, serum, settled, simplify, simplifying, Smart, subsequently, Syncytial, Tangible, telecommuting, TNW, trading, treated, Unit, unsure, waived, workforce, Worth, WSJ, York
Current reports
8-K
Submission of Matters to a Vote of Security Holders
29 Jun 22
8-K
Entry into a Material Definitive Agreement
14 Mar 22
8-K
Changes in Registrant's Certifying Accountant
22 Dec 21
8-K
Abmc Reports Third Quarter 2021 Results
18 Nov 21
8-K
Entry into a Material Definitive Agreement
24 Oct 21
8-K
Abmc Reports Second Quarter 2021 Results
18 Aug 21
8-K
Submission of Matters to a Vote of Security Holders
29 Jun 21
8-K
Abmc Reports First Quarter 2021 Results
20 May 21
8-K
Abmc Reports Fourth Quarter and Year End 2020 Results
15 Apr 21
8-K
Entry into a Material Definitive Agreement
3 Mar 21
Registration and prospectus
424B3
Prospectus supplement
12 Jan 21
S-1/A
IPO registration (amended)
7 Jan 21
S-1
IPO registration
6 Apr 14
25-NSE
Exchange delisting
5 Oct 09
S-3/A
Shelf registration (amended)
4 May 09
S-3
Shelf registration
14 Apr 09
REGDEX
Notice of sale of securities
17 Aug 08
25-NSE
Exchange delisting
17 Aug 06
POS AM
Prospectus update (post-effective amendment)
28 Jun 06
Other
EFFECT
Notice of effectiveness
12 Jan 21
CORRESP
Correspondence with SEC
7 Jan 21
UPLOAD
Letter from SEC
3 Jan 21
EFFECT
Notice of effectiveness
13 Apr 14
UPLOAD
Letter from SEC
19 Jan 10
CORRESP
Correspondence with SEC
30 Dec 09
UPLOAD
Letter from SEC
21 Dec 09
CORRESP
Correspondence with SEC
9 Jun 09
EFFECT
Notice of effectiveness
9 Jun 09
CORRESP
Correspondence with SEC
7 Jun 09
Ownership
SC 13G/A
AMERICAN BIO MEDICA / Sternberg Stuart ownership change
29 Nov 21
4
AMERICAN BIO MEDICA / Stuart Sternberg ownership change
29 Nov 21
SC 13G/A
AMERICAN BIO MEDICA / Sternberg Stuart ownership change
26 Oct 21
3
AMERICAN BIO MEDICA / Stuart Sternberg ownership change
26 Oct 21
SC 13D
AMERICAN BIO MEDICA / MORONEY JOHN J ownership change
26 Jul 21
4
AMERICAN BIO MEDICA / JOHN J MORONEY ownership change
19 Jul 21
SC 13D
AMERICAN BIO MEDICA / MORONEY JOHN J ownership change
1 Jun 21
SC 13G/A
AMERICAN BIO MEDICA / Sternberg Stuart ownership change
14 Jan 21
4
AMERICAN BIO MEDICA / Chaim Davis ownership change
2 Jul 20
4
AMERICAN BIO MEDICA / Jean Neff ownership change
2 Jul 20